chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a 44-year-old female who received a Yellow Fever vaccination on 04/29/2004. She relates that she had no difficulty with the vaccination initially.  She did not notice any difficulty until 05/03/04 when after showering she noticed that the injection site area was red, inflamed, warm to touch and itchy. She denies any reaction to prior vaccinations, including yellow fever. She denied any nausea, vomiting, diarrhea, fever, or chills. She denies any numbness, tingling or sensory changes in the left upper extremity. She prevents for evaluation of her adverse event.
Neck pain; low back pain; loss sense of taste 5 days after; extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 42-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration in left arm on 02Apr2021 at 03:30 PM (at the age of 42-years-old) as dose 1, single for COVID-19 immunization. Patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and patient has not been tested for COVID-19 since the vaccination. On 05Apr2021, patient experienced Neck pain, low back pain, loss sense of taste 5 days after and extreme fatigue. No treatment was received in response to events. The outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Per Patient, developed redness of the face and neck, c/o itching. Seen by MD on 3/10, prescribed methylprednisolone 4mg X 6 days. Seen again by MD on 3/31 prescribed mometasone furoate cream and instructed to take Benadryl prn. Facial skin is now peeling.
Four patients received an expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received HBV (Engerix B) (batch number 73H93, expiry date 10th January 2022) for prophylaxis.   On 28th April 2022, the patient received Engerix B. On 28th April 2022, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 29-APR-2022 Reporter's Comment: The reporter reported that the patient received an expired dose of Engerix-B vaccine. The reporter consented to follow up. Additional Supportive Information: The reporter reported that the patient received an expired dose of Engerix-B vaccine, which led to expired vaccine used. This case is one of 4 cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR072337:Same reporter US-GLAXOSMITHKLINE-US2022AMR072338:Same reporter US-GLAXOSMITHKLINE-US2022AMR072336:Same reporter
Started with severe headache and sinus congestion.  Progressed to SOB.  Patient took cold medicine to help with headache and congestion and that seemed to improve the SOB.  No Medical treatment was sought.
About 3 months after receipt of second dose of  Moderna vaccine, patient noticed a decrease in visual acuity described as blurry vision, and she also complains of "pain behind her eyeballs."
INDIVIDUAL THAT ADMINISTERED VACCINE DID NOT MIX IT PER MANUFACTURER INSTRUCTIONS. THE MEN A (ORANGE CAP) WAS NOT MIXED WITH MENCYW(GREY CAP) BUT RATHER WITH THE DILUENT FOR THE LIVE VACCINE SOLUTION. PATIENT DID NOT GET THE COMPLETE DOSE OF MENVEO. MOTHER INFORMED PATIENT WILL NEED DOSE REPEATED .
This study case was received on 27 February 2013 from the investigator in a trial. A male subject (age and birth date not reported) with no relevant past medical history, developed possible myopericarditis five days after he received the following vaccines: an injection of ACAM2000, SP Biologics Co., (lot number, route, site and side not reported) and concomitantly, an injection of TYPHOID VACCINE, manufacturer unknown, (lot number, route, site and side not reported) on 18 January 2012. On 23 January 2012, five days post vaccination, the subject developed possible myopericarditis, considered moderate severity, with reported moderate on/off left sided sharp chest pain, occurring "a couple times per day" and present two days later. The subject was referred for care for possible myopericarditis. Study "Troponins" and electrocardiogram (ECG) were reported as normal on unspecified dates. According to investigator, there was low suspicion for myopericarditis. The doctor (MD) at clinic reported chest pain. No treatments were prescribed. The stop date of adverse event and outcome was reported as resolved on an unspecified date in 2012 (and outcome was also reported as lost to follow-up). According to the investigator, the event of possible myopericarditis was considered an other important medical event and possibly related to the trial product. Documents held by sender: None.
tested positive for COVID 19  Narrative:  The patient got the first dose of the COVID vaccine on 2/11/21. He tested positive for COVID on 3/12/21. The patient has been asymptomatic since diagnosis.
Started morning after my second dose swollen arm, swollen lump in my arm bit and left side of my neck, extremely painful where I could not lift my arm or move it, then my entire body felt very stiff and painful just like my arm, fever of 100-102 off and on and currently having fever on June 16th at 1:56pm,  chills, bad nausea, vomited 6 times since June 15th, bad headache, stiff neck, random severe jolts of pain through my jaw and in my knees,  very weak, getting random dizzy spells that hit out of nowhere. Called into work because my symptoms are too bad to work in retail business with no air conditioning.
injection site pain, tiredness, headache, muscle pain, chills, fever, nausea,  feeling unwell
6 days after TD to L/upper arm, developed redness, pain & itching to area. Treatment: warm compresses PRN, Benadryl 25mg po every 6 hrs PRN itching, Keflex 250mg 2 PO TID.
Per employer, she received flu vaccine at work on 24-OCT-2006 at approximately 8:15 am. The only symptom reported on Thursday was "red eyes." 25-OCT-2005 when she got out of bed she noted a tingling sensation of both her tongue and face. When she looked in the mirror she observed that her face was flushed and both lips were swollen. She denied any difficulty with breathing or swallowing.
My right arm in which I received the shot got sort of numb, sore and tingly from the shoulder all the way down to the finger tips. The whole arm really aches and I t can feel really badly. The first couple of days it lasted a couple of minutes and subsided., but it happened three or four times a day  Gradually, the symptoms were only once or twice a day for a shorter period of time and less severe. The symptoms seem to occur without cause and effect, meaning I can?t see anything that caused the reaction.   The symptoms continue but are much diminished in discomfort.
Pt reports that after more than 24 hours after vaccine, her lips started to swell. Visibly looks "plump," but no respiratory problems. No new drugs or products being used during this period either. No reaction at time of vaccination.  Advised pt that if she has difficulty breathing to go to ER immediately, to evaluate if there were any medication/food/environmental changes to rule out other causes, and advised pt to f/u with doctor.  Pt said she has appointment with dermatologist in next few days.
Pfizer 9/13/21, 10/10/21. Positive on 8/20/22
Flu like symptoms began about 24 hours after the injection.  General malaise, diarrhea and loss of appetite followed.  My husband was so tired he slept the first day for about 4 hours that afternoon . On the second day he exercised at the gym for 30 mintues and came home feeling  ill with an upset stomach , sour brash/reflux, body aches, several episodes of diarrhea, sweating and fatigue.  He slept  all afternoon and all night as well. Today, he felt well enough to each a light breakfast. The first injection did not produce any symptoms other than local redness and pain at the injection site.
I received Moderna COVID-19 VACCINE EUA. The day after the vaccine my temperature varied from 98.2 to 100.3 degrees, going up and down. Two days after it varied from 97.5 to 99.5 degrees. I experienced pain at the injection site. I felt somewhat nauseous the first day after, and occasionally nauseous the second day. I experienced chills and sweats from 12 hours after the vaccine until 48 hours later. There were moments where my body felt extremely sensitive. Pain shot through various parts of me randomly (not often). The day after the vaccine I was exceptionally tired. I was only awake for a few hours before 2pm that day. (I'm typically awake for 8 hours at that point.) Also, I had a severe headache the day after the vaccine, and a mild headache the following day.
patient reports feeling  lightheaded, dizzy and difficulty, uncomfortable swallowing.  No short of breath.  Gave Benadryl 50mg at 11:23am.  Lungs clear.  At 11:43am patient reports symptoms resolved.
Patient was administered vaccine that was improperly stored (in freezer for too long and considered expired by manufacturer at date of administration due to lack of study data). Patient acknowledged recommendation and will schedule revaccination with us soon.
Approximately 12 hours after receiving JEV and Rabies vaccines, patient noted myalgia, sweating, and transient dyspnea
Received vaccination 6/12. Very next evening rash started on thighs. Throughout the following week rash spread to legs, trunk and arms. Seen by provider, 6/22/15.
Patient actually experiencing no adverse reaction at this time. Patient was given an Influenza vaccine in the doctor's office then came to the pharmacy and received a second Influenza vaccine in the same day. She was asked a minimum of two times which vaccine she wished to receive. Each time she answered the flu shot. Received shot around 11:57 AM on 10/16/2018. Poison Control called around 5:30PM after it was discovered that the patient had been given two flu vaccine. Poison control stated that no live vaccine and they were unaware of any toxicity. Suggested to call the Drug Company and monitor for adverse reactions. Drug Company called 11:30AM 10/17/2018 and the pharmacy was informed that there was data, no studies, and no safety data to support more than one shot in a season. Suggested to continue to monitor and report side effects.
FEVER OF 102.0 F AND VOMITING FOR 3 CONSECUTIVE NIGHTS (NIGHTS ONLY) MOM STATES PT FINE DURING DAY BUT GETS SICK AT NIGHT.
Tender, large ipsilateral axillary lymph node appearing after the injection. Regressing some by 3 days later.
This spontaneous report was received from a certified medical assistant referring to multiple unspecified patients of unknown age. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On or after 02-MAY-2018, on multiple unspecified dates, the patients were vaccinated with improperly stored ROTATEQ, oral for prophylaxis (dose, route of administration, lot number and expiration date were not reported). No adverse events were reported. The vaccine was exposed to a temperature excursion of 47°F to 77°F with a time frame of 2 hours and 10 minutes. There was no previous temperature excursion. A "data logger" was involved.
Discharge Provider: MD Primary Care Physician at Discharge: DO  Admission Date: 6/10/2022  PRESENTING PROBLEM: Thrombocytopenia [D69.6] Febrile neutropenia [D70.9, R50.81] Electrolyte abnormality [E87.8] Pulmonary embolism, unspecified chronicity, unspecified pulmonary embolism type, unspecified whether acute cor pulmonale present [I26.99] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute respiratory failure with hypoxia [J96.01]   HOSPITAL COURSE:   Patient is a 78 y.o. female with history of active small cell lung carcinoma s/p radiation therapy and was on active chemotherapy (last session completed two weeks ago), COPD, HTN who presented initially due to sepsis in the setting of febrile neutropenia who was also found to be positive for COVID-19. She was admitted on 6/10 from the infusion clinic after having 1-week of worsening shortness of breath, cough, and chills. She had sepsis due to Pseudomonas bacteremia and pneumonia. During hospitalization she declined and developed AHHRF was placed on BiPap with worsening VBG and was transferred to ICU and subsequently intubated on 6/12.    During her stay she was also found to have a new acute thrombus right lower extremity and small pulmonary emolism. She had severe pancytopenia with platelets <10 so an IVC filter placed on 6/12 and unable to anticoagulate. She then suffered from worsening renal failure and required renal replacement therapy. Found to have worsening respiratory status, as well as a candida bacteremia. Shock persisted. A family meeting on 6/21/2022 with first degree relatives agreed upon comfort care measures given that her wishes were not to be kept alive on life support. Family presented at bedside and comfort care measures in place.   Patient was pronounced at 6:54pm on 06/21/2022 secondary to respiratory failure in the setting of pseudomonas pneumonia, covid pneumonia, and candida bacteremia. Called and updated family over the phone
Headache; Fatigue; Joint pain; pounding headache; freezing; nauseated; body aches; stabbing pains in her joints/joint pain; fever; Fatigue/major fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (pounding headache), FREEZING PHENOMENON (freezing), NAUSEA (nauseated), MYALGIA (body aches) and ARTHRALGIA (stabbing pains in her joints/joint pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cancer. Concurrent medical conditions included Hypertension and Drug allergy (Allergies to Dicloxacillin.). Concomitant products included LOSARTAN and OMEPRAZOLE for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced HEADACHE (pounding headache), FREEZING PHENOMENON (freezing), NAUSEA (nauseated), MYALGIA (body aches), ARTHRALGIA (stabbing pains in her joints/joint pain), PYREXIA (fever) and FATIGUE (Fatigue/major fatigue). On 08-Feb-2021, the patient experienced HEADACHE (Headache), FATIGUE (Fatigue) and ARTHRALGIA (Joint pain). At the time of the report, HEADACHE (pounding headache), FREEZING PHENOMENON (freezing), NAUSEA (nauseated), MYALGIA (body aches), ARTHRALGIA (stabbing pains in her joints/joint pain), PYREXIA (fever), FATIGUE (Fatigue/major fatigue), HEADACHE (Headache), FATIGUE (Fatigue) and ARTHRALGIA (Joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Treatment medication details were not provided.
Initial unsolicited case received from a consumer on 27 Sep 2017. This case involves a female patient (age not reported) who was vaccinated with a dose of FLUZONE .5 QUADRAVALENT (Batch number, expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date. Patient medical history and concomitant medications were not reported. On an unknown date, following the vaccination, the patient developed chills, fever, body aches and blister in and around mouth. Relevant lab tests and corrective treatment were not reported. The outcome of all the events were not reported. List of documents held by sender: none.
Patient came into the doctor's office for a check-up.  Patient recieved the pneumococcal vaccine.  One hour later the patient started expirencing nausea and salivatory.  Patient then went to the emergency room and had one episode of emesis.  Patient did not have a temperature or a local reaction to the injection.
24MAY redness & swelling of arm;arm tender & warm;tx ice bag & EES;DPH given;25MAy ER visit erythema rt upper arm  w/edema med cont;
That vax hurt; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided are as follows: The age at vaccination was not reported. The patient received Shingles vaccine and that vaccine(vax) hurt. No further details were provided.
3-11-21 pain in groin on right side/leg weakness around 2:00pm better next day just sore arm., Fatigue on 3-12 & 3-13. On 3-14 developed intense pain right side lower back and kidney.  3-16 went to Doctor as felt I had kidney infection but urine checked find, she thought it was muscle spasms. 3-19 broke out with shingles and back to doctor on 3-22 and given Acyclovir and Gabapentin. 3-23 went to ER. In as woke with pain so severe I broke out in sweat and threw up.  Gave me Hydrocodone, nurse commented was worse break out she had ever seen.  Internal pain is worse than the rash which is naval to spine and 3 to 4 " wide.
Increase in INR value. Patient previously stable and well controlled on warfarin. Dosage decrease required. Stable on 2.5mg daily since 2018. Dosage reduced to 2mg daily.
Individual reported positive covid result on 12/19/21.  Symptomatic with congestion and cough still ongoing. He's isolating for 10 days and will callback for follow up. Antibody testing ordered after isolation period ends.
The sides of my tongue are swollen and bumpy and my neck is stiff amd I have a headache . I have pictures of my tongue.
Reactions at the site of Injection; This case was reported by a other health professional via call center representative and described the occurrence of injection site reaction in a patient who received DTPa (Reduced antigen) (Boostrix) (batch number 43E4T, expiry date 1st September 2021) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, less than 6 months after receiving Boostrix, the patient experienced injection site reaction. On an unknown date, the outcome of the injection site reaction was unknown.   It was unknown if the reporter considered the injection site reaction to be related to Boostrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient had reactions at the site of injection with Boostrix. The batch number reported for Boostrix(43E47) did not exist and was updated to 43E4T, as per sales database. The reporter consented to follow up. This was one of the 6 cases, reported by the same reporter.
Information has been received from a physician concerning a patient who on 17-JUL-2007 was vaccinated PO with a first dose of Rotateq. Subsequently, on 18-JUL-2007, the patient experienced vomiting, diarrhea and crying. The patient was sent to the hospital, but it was unknown is she/he was admitted. An ultrasound and an X-ray were obtained. It was found that the patient did not have intussusception or pyloric stenosis. No further information was provided. There was no product quality complaint. Additional information has been requested.
Blood sugar readings have increased 15% since having COVID-19 vaccine. Have not returned to normal.  Severe symptoms lasted 48 hours  High fever Chills Aches Lethargy
Rash that has spread down my arm to just above the elbow. It just itches and not sure what I should apply to heal it
Tested positive for Covid 19.  Symptoms include body aches, headache, congestion and tired
I got a kidney infection within a few days of taking Vivotif oral typhoid vaccine. I have had reoccurring bladder infections since then treated with multiple antibiotics, and I still have not recovered.
2/12/2022 Tuesday doctors were certain there was a blood clot. They confirmed with a Doppler ultrasound. Clot was in left leg, most of the leg was affected. Started XARELTO that day. After 3 days pain subsided and got better but lingers to this day.
run-down Feeling / TIREDNESS; Body aches; Flu-like symptoms; Lung irritation; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 54-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th January 2021, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 16th January 2021, 1 days after receiving Shingrix, the patient experienced fatigue, general body pain, influenza-like symptoms and lung irritation. On an unknown date, the outcome of the fatigue, general body pain, influenza-like symptoms and lung irritation were not recovered/not resolved.   It was unknown if the reporter considered the fatigue, general body pain, influenza-like symptoms and lung irritation to be related to Shingrix.  Additional details were provided as follows: The patient was reporting for himself. The patient received Shingrix in left deltoid. About 24 hours after receiving Shingrix, the patient began to experience a run-down feeling, flu-like symptoms, body aches, tiredness and lung irritation.  The patient stated, the symptoms had not resolved although they were not as bad as they were.   No lot number or expiration date was known for this vaccine. The reporter consented to follow up.
it was red; was Itchy; Rash appeared at several locations on his body; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (it was red), PRURITUS (was Itchy) and RASH (Rash appeared at several locations on his body) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus insulin-dependent. Concomitant products included METFORMIN, VITAMINS NOS, CURCUMA LONGA (TURMERIC [CURCUMA LONGA]), RAMIPRIL, ATORVASTATIN, RIVAROXABAN (XARELTO) and INSULIN for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ERYTHEMA (it was red), PRURITUS (was Itchy) and RASH (Rash appeared at several locations on his body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event following immunisation, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (ANTI ITCH CREAM [DIPHENHYDRAMINE HYDROCHLORIDE]) (topical) for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, ERYTHEMA (it was red), PRURITUS (was Itchy) and RASH (Rash appeared at several locations on his body) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Very fearful - Hyperventilating - trembling before injection. Became faint approx 3 min after inj. Placed in shock position, color returned slowly, got patient sitting position approx 5 min later became faint pale - head dropped back. Nonresponsive, couldn't /// type reaction. Placed in shock positition . A fam response to mother. ///// EMS called for assistance.
Narrative: 3:40 pm 1/20/21 second dose. 0900 1/21/21: headache, nausea/vomiting, sore arm. Today - sleepy, fatigued, mild nausea but has not eaten today. Itching at injection site.
After pt received Tdap and GARDASIL today, pt became lightheaded (about 5 min after vaccines were given). Pt was helped to the floor by RN and pt's mother. Pt was pale, pt c/o vision closing in on her LOC?. Pt's eyes remained open however did not respond to questions for less than 1 min, pt began to feel better was observed in office after 5-10 min pt walked out with mother.
Patient developed generalized rash, itchy and erythema onset with chills, fever sore arm